trending Market Intelligence /marketintelligence/en/news-insights/trending/hGlXu6wNVtp6ePYEI1gBKg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Report: PE investors in talks to buy India's animal healthcare company Sequent

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Street Talk - Ep. 64: Coronavirus jumpstarts digital adoption

Street Talk Podcast

Street Talk - Ep. 63: Deal talks continue amid bank M&A freeze, setting up for strong Q4

Street Talk Podcast

Street Talk - Ep. 62: 'Brutal' outlook for oil demand offers banks in oil patch no relief

Report: PE investors in talks to buy India's animal healthcare company Sequent

Private equity investors including U.S.-based Advent International Corp. and India-based Kedaara Capital Investment Managers Ltd. are in early discussions to acquire Indian animal healthcare company Sequent Scientific Ltd., The Economic Times (India) reported, citing two people aware of the development.

A proposed deal is expected in the range of 25 billion Indian rupees, the publication said, citing the sources, who added that promoters and an existing private equity investor will exit. JP Morgan is running the sale process, which will involve an open offer, the news outlet noted.

Private equity firm Ascent Capital Advisors owns a 5% stake in the listed company, and the founder promoters of Sequent own a combined about 56.5% stake.

Representatives for Advent and Sequent declined to comment, while Kedaara did not respond to a request for comment by the publication.

As of Jan. 15, US$1 was equivalent to 70.71 Indian rupees.